Literature DB >> 16318038

Differences in U.S. hospital service utilization between traditional Medicare and Medicare HMO patients.

Lee Revere1, Alan Sear.   

Abstract

This study examines the differences between traditional U.S. Medicare and Medicare HMO Florida inpatient hospital utilization during the years 1992-1998, using nine high volume Diagnosis Related Groups. Utilization was measured by the number of ancillary services consumed, as well as the charges for those services. The analyses controlled for differences in utilization due to patient age, race, hospital size, year and market differences in hospital costs. Patient data were severity-adjusted and the analysis focused on the patients at the highest severity level. The study found that Medicare HMO patients with chronic diseases at the highest severity of illness level consumed significantly more services than traditional Medicare patients with the same chronic diseases. It was concluded that these Medicare HMO patients were either sicker (despite the severity adjustment) than the traditional Medicare patients and/or Medicare HMOs used different production processes than traditional Medicare, perhaps in order to minimize length of stay. Medicare HMO patients with acute illnesses at the highest severity level did not, in general, consume significantly more services than traditional Medicare patients at the same level of severity for the same diagnoses. The results imply that Medicare policy with regard to HMO expansion may not result in cost savings, and may, instead, result in higher costs if the proportion of the Medicare population hospitalized with chronic illnesses increases.

Entities:  

Mesh:

Year:  2004        PMID: 16318038

Source DB:  PubMed          Journal:  J Health Hum Serv Adm        ISSN: 1079-3739


  1 in total

1.  Understanding variations in Medicare Consumer Assessment of Health Care Providers and Systems scores: California as an example.

Authors:  Donna O Farley; Marc N Elliott; Amelia M Haviland; Mary Ellen Slaughter; Amy Heller
Journal:  Health Serv Res       Date:  2011-06-03       Impact factor: 3.402

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.